Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 1;78(2):197-207.
doi: 10.1001/jamaneurol.2020.3962.

Association Between Ambient Air Pollution and Amyloid Positron Emission Tomography Positivity in Older Adults With Cognitive Impairment

Affiliations

Association Between Ambient Air Pollution and Amyloid Positron Emission Tomography Positivity in Older Adults With Cognitive Impairment

Leonardo Iaccarino et al. JAMA Neurol. .

Abstract

Importance: Amyloid-β (Aβ) deposition is a feature of Alzheimer disease (AD) and may be promoted by exogenous factors, such as ambient air quality.

Objective: To examine the association between the likelihood of amyloid positron emission tomography (PET) scan positivity and ambient air quality in individuals with cognitive impairment.

Design, setting, and participants: This cross-sectional study used data from the Imaging Dementia-Evidence for Amyloid Scanning Study, which included more than 18 000 US participants with cognitive impairment who received an amyloid PET scan with 1 of 3 Aβ tracers (fluorine 18 [18F]-labeled florbetapir, 18F-labeled florbetaben, or 18F-labeled flutemetamol) between February 16, 2016, and January 10, 2018. A sample of older adults with mild cognitive impairment (MCI) or dementia was selected.

Exposures: Air pollution was estimated at the patient residence using predicted fine particulate matter (PM2.5) and ground-level ozone (O3) concentrations from the Environmental Protection Agency Downscaler model. Air quality was estimated at 2002 to 2003 (early, or approximately 14 [range, 13-15] years before amyloid PET scan) and 2015 to 2016 (late, or approximately 1 [range, 0-2] years before amyloid PET scan).

Main outcomes and measures: Primary outcome measure was the association between air pollution and the likelihood of amyloid PET scan positivity, which was measured as odds ratios (ORs) and marginal effects, adjusting for demographic, lifestyle, and socioeconomic factors and medical comorbidities, including respiratory, cardiovascular, cerebrovascular, psychiatric, and neurological conditions.

Results: The data set included 18 178 patients, of which 10 991 (60.5%) had MCI and 7187 (39.5%) had dementia (mean [SD] age, 75.8 [6.3] years; 9333 women [51.3%]). Living in areas with higher estimated biennial PM2.5 concentrations in 2002 to 2003 was associated with a higher likelihood of amyloid PET scan positivity (adjusted OR, 1.10; 95% CI, 1.05-1.15; z score = 3.93; false discovery rate [FDR]-corrected P < .001; per 4-μg/m3 increments). Results were similar for 2015 to 2016 data (OR, 1.15; 95% CI, 1.05-1.26, z score = 3.14; FDR-corrected P = .003). An average marginal effect (AME) of +0.5% (SE = 0.1%; z score, 3.93; 95% CI, 0.3%-0.7%; FDR-corrected P < .001) probability of amyloid PET scan positivity for each 1-μg/m3 increase in PM2.5 was observed for 2002 to 2003, whereas an AME of +0.8% (SE = 0.2%; z score = 3.15; 95% CI, 0.3%-1.2%; FDR-corrected P = .002) probability was observed for 2015 to 2016. Post hoc analyses showed no effect modification by sex (2002-2003: interaction term β = 1.01 [95% CI, 0.99-1.04; z score = 1.13; FDR-corrected P = .56]; 2015-2016: β = 1.02 [95% CI, 0.98-1.07; z score = 0.91; FDR-corrected P = .56]) or clinical stage (2002-2003: interaction term β = 1.01 [95% CI, 0.99-1.03; z score = 0.77; FDR-corrected P = .58]; 2015-2016: β = 1.03; 95% CI, 0.99-1.08; z score = 1.46; FDR-corrected P = .47]). Exposure to higher O3 concentrations was not associated with amyloid PET scan positivity in both time windows.

Conclusions and relevance: This study found that higher PM2.5 concentrations appeared to be associated with brain Aβ plaques. These findings suggest the need to consider airborne toxic pollutants associated with Aβ pathology in public health policy decisions and to inform individual lifetime risk of developing AD and dementia.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Ms Hanna reported receiving grants from the American College of Radiology. Dr Hillner reported receiving grants from the Alzheimer's Association. Dr Siegel reported receiving grants from the American College of Radiology during the conduct of the study and ImaginAb Inc; personal fees from Avid Radiopharmaceuticals, Curium Pharma, GE Healthcare, Siemens Healthineers, and Capella Imaging outside the submitted work; and grants and personal fees from Progenics Pharmaceuticals and Blue Earth Diagnostics. Dr Whitmer reported receiving grants from the National Institutes of Health (NIH) and the Alzheimer’s Association. Dr Carrillo reported being a full-time employee of the Alzheimer’s Association. Dr Gatsonis reported receiving grants from the American College of Radiology during the conduct of the study. Dr Rabinovici reported receiving grants from the American College of Radiology, Alzheimer's Association, Avid Radiopharmaceuticals, GE Healthcare, and Life Molecular Imaging during the conduct of the study; personal fees from GE Healthcare, Axon Neurosciences, Eisai, Merck, and Johnson & Johnson; and grants from the NIH, Rainwater Charitable Foundation, Association for Frontotemporal Degeneration, and Michael J. Fox Foundation outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Geographical Distribution of Imaging Dementia—Evidence for Amyloid Scanning Study Participants
Participants were mapped by the centroid of the residential zip codes. To maintain confidentiality, a perturbation approach was adopted by adding random noise (jittering) to residential zip code coordinates, displacing them within a 50 by 50-km grid.
Figure 2.
Figure 2.. Estimated Levels of Fine Particulate Matter (PM2.5) and Ground-Level Ozone (O3)
Mean daily PM2.5 and mean daily 8-hour maximum O3 levels among participants across geographical locations were estimated for both 2002 to 2003 and 2015 to 2016 using the Downscaler model. Data are provided for both exposure time windows and expressed in micrograms per cubic meter (μg/m3) for PM2.5 and in parts per billion (ppb) for O3. To maintain confidentiality, a perturbation approach was adopted by adding random noise (jittering) to residential zip code coordinates, displacing them within a 50-by-50 km grid.
Figure 3.
Figure 3.. Associations Between Exposure to Fine Particulate Matter (PM2.5) and Ground-Level Ozone (O3) and Amyloid Positron Emission Tomography (PET) Scan Positivity
A, Odds ratios (ORs) are expressed as changes compared with increases of 4 μg/m3 for PM2.5 and 5 parts per billion (ppb) for O3 (ie, the observed respective interquartile ranges in 2002 to 2003). B, Adjusted OR estimations in the full sample with PM2.5 considered as quartile (Q) data. Error bars show 95% CIs. Marginal effects plots are shown for continuous (C) and quartiles (D) data. C, Solid lines indicate linear fit, and the shaded area indicates 95% CIs. D, Quartile 1 is the lowest (least polluted) quartile, and quartile 4 is the highest (most polluted) quartile.

Comment in

Similar articles

Cited by

References

    1. Winblad B, Amouyel P, Andrieu S, et al. . Defeating Alzheimer’s disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15(5):455-532. doi:10.1016/S1474-4422(16)00062-4 - DOI - PubMed
    1. Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer’s disease. Nat Rev Dis Primers. 2015;1(1):15056. doi:10.1038/nrdp.2015.56 - DOI - PubMed
    1. Eid A, Mhatre I, Richardson JR. Gene-environment interactions in Alzheimer’s disease: a potential path to precision medicine. Pharmacol Ther. 2019;199:173-187. doi:10.1016/j.pharmthera.2019.03.005 - DOI - PMC - PubMed
    1. Finch CE, Kulminski AM. The Alzheimer’s disease exposome. Alzheimers Dement. 2019;15(9):1123-1132. doi:10.1016/j.jalz.2019.06.3914 - DOI - PMC - PubMed
    1. Cohen AJ, Brauer M, Burnett R, et al. . Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015. Lancet. 2017;389(10082):1907-1918. doi:10.1016/S0140-6736(17)30505-6 - DOI - PMC - PubMed

Publication types

Substances